Syntron Bioresearch
Syntron Bioresearch, Inc. specializes in manufacturing rapid in vitro diagnostic tests and detection readers, focusing on fertility and over-the-counter tests for ovulation and pregnancy. The company is licensed as a Medical Device Establishment by the US FDA and the State of California Department of Health Services, and is ISO certified. Their intended clients include healthcare providers and individuals seeking reliable diagnostic solutions. Syntron is committed to meeting the needs of its customers with high-quality products and services.
Incident Details
- Threat Group
- dragonforce
- Victim / Organization
- Syntron Bioresearch
- Website / Domain
- syntron.net
- Industry Sector
- Healthcare
- Country / Region
- 🇺🇸 US
- Date Discovered
- Sunday, July 26, 2026
What This Listing Means
Posting on dragonforce's ransomware leak site typically signals that the threat actor claims to have:
- ▸Gained unauthorized access to the organization's network via phishing, exposed credentials, or an unpatched vulnerability
- ▸Exfiltrated sensitive data — potentially including financial records, PII, customer data, or trade secrets
- ▸Deployed ransomware to encrypt systems and disrupt operations
- ▸Issued a ransom demand with a deadline to publish all stolen data publicly if unpaid
🇺🇸 US-based organizations hit by ransomware may have mandatory breach notification obligations under state laws, HIPAA (healthcare), SEC regulations (public companies), or CISA guidelines. The notification window is typically 72 hours from discovery.
Open Source Investigation
Is This Your Organization?
Security Arsenal provides 24/7 ransomware incident response. We contain active attacks, support ransom negotiation decisions, perform forensic analysis, and recover your data.
Get Emergency ResponseIR Services OverviewProtect Your Organization
- AlertMonitor
Dark web & ransomware monitoring for your domains
- Managed SOC & MDR
24/7 threat detection and response
- Penetration Testing
Find ransomware entry points before attackers do